Biotech · Private company
DiscGenics, Inc.
Track this companyFree. Adds DiscGenics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- IDCT (rebonuputemcel)Phase 3 · Degenerative Disc DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sham (No Treatment)Phase 3 · Degenerative Disc DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- IDCTPhase 1 · Degenerative Disc DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sodium HyaluronatePhase 1 · Degenerative Disc DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc DiseasePHASE3 · RECRUITING · started Dec 23, 2025ClinicalTrials.gov NCT07254806 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc DegenerationPHASE1 · COMPLETED · started Feb 26, 2018ClinicalTrials.gov NCT03347708 · fetched Nov 12, 2026